Fine-tuning IVF laboratory key performance indicators of the Vienna consensus according to female age

• Published in: Journal of assisted reproduction and genetics Vol. 39; no. 4; pp. 945 - 952
• Main Authors: Zacà, Carlotta, Coticchio, Giovanni, Vigiliano, Vincenzo, Lagalla, Cristina, Nadalini, Marco, Tarozzi, Nicoletta, Borini, Andrea
• Format: Journal Article
• Language: English
• Published: New York Springer US 01.04.2022; Springer Nature B.V
• Subjects: Adult; Age groups; Assisted Reproduction Technologies; Blastocyst; Business metrics; Consensus; Embryos; Female; Fertilization; Fertilization in Vitro; Gynecology; Human Genetics; Humans; Laboratories; Medicine; Medicine & Public Health; Pregnancy; Pregnancy Rate; Reproductive Medicine; Retrospective Studies; Pregnancy; IVF; Embryo; Fertilization; Indicators; Blastocyst
• ISSN: 1058-0468; 1573-7330; 1573-7330
• DOI: 10.1007/s10815-022-02468-2

Purpose To test the validity of the Vienna consensus laboratory key performance indicators (KPIs) to monitor the outcome of treatments involving women of different age ranges. Methods The retrospective cohort study included 862 complete IVF/ICSI cycles carried out between January 2014 and May 2021. All embryos of each cycle cohort were subject to extended culture. The overall population was divided into two groups according to female age: the Vienna consensus (≤ 39 years) and older female age (≥ 40 years). We compared outcomes of a selection of the Vienna performance indicators (PIs) and KPIs, with a focus on measures relevant to embryo cleavage and blastocyst formation. A possible association between total good blastocyst development rate (TGBDR) and cumulative clinical pregnancy rate (CPR) was also assessed. Results No differences were observed in fertilization and embryo cleavage KPIs between the Vienna consensus and the older female age group (standard IVF fertilization, 67.2 vs. 67.3; ICSI fertilization, 72.3 vs. 75.3; day 2 development, 57.6% vs 58.7%; day 3 development, 52.4% vs. 50.7%, respectively). TGBDR was lower in the older female age group (45.5% vs. 33.4% p  < 0.001). Multivariate logistic regression analysis indicated female age as a factor independently associated with TGBDR. Clinical outcomes significantly decreased with increasing female age. Conclusion The study suggests that, while most laboratory outcome measures are reliably applicable irrespective of female age, KPIs describing extended embryo culture should be fine-tuned in consideration of older female age.